Dr Richard Torbett has been named as the new Chief Executive of the Association of the British Pharmaceutical Industry (ABPI) replacing Mike Thomson.
Thompson, who has served as Chief Exec since March 2016, announced his intention to step down back in July and now his replacement has been named.
Dr Torbett joined the ABPI in July 2015 and is currently Executive Director of Economic, Health and Commercial Policy where he was responsible for negotiating the 2019 Voluntary Scheme for Medicine Pricing and Access.
He has spent the last 14 years working across several senior roles in the pharmaceutical industry including as Chief Economist at the European Federation of Pharmaceutical Industries and Associations (EFPIA) and Senior Director and Head of International Affairs at Pfizer. Prior to joining the pharmaceutical industry, he worked as a government economist.
He was appointed following a competitive, external recruitment process with an executive search agency and was unanimously selected by the ABPI Board.
“Richard is a hugely respected figure within our industry both internationally and in the UK,” said ABPI President Haseeb Ahmad.
“We share an ambition to make the UK the best place in the world to research, develop and use new medicines and I look forward to working with him.”